制藥網(wǎng)>產(chǎn)品庫>原料藥中間體、制劑>制劑>其它制劑>>英國NIBSC標準物質(zhì)

英國NIBSC標準物質(zhì)

參考價	面議

參考價

面議

具體成交價以合同協(xié)議為準

公司名稱上?？戮S化學(xué)技術(shù)有限公司
品牌
型號
所在地上海市
廠商性質(zhì)代理商
更新時間2017/9/28 16:08:52
訪問次數(shù)1600

產(chǎn)品標簽:

歐洲藥典標準品日本藥典標準品英國藥典標準品美國藥典標準品藥典標準品

在線詢價收藏產(chǎn)品查看電話同類產(chǎn)品

聯(lián)系我們時請說明是制藥網(wǎng) 上看到的信息，謝謝!

索取相關(guān)資料

公司介紹主營產(chǎn)品

我司主要供應(yīng)產(chǎn)品：

1 法定藥典標準品（如中檢所、美國中草藥標準品ChromaDex、USP、EP、BP、JP等），

2 其它標準品（如美國標準局NIST、歐洲標準局IRRM、美國聚合物標準品APSC、同位素標準品Omicron等）

3 藥物代謝雜質(zhì)類產(chǎn)品（如英國LGC,加拿大TRC,TLC等），

4 常用化學(xué)試劑（如脂質(zhì)類試劑，同位素試劑，Sigma,TCI，中檢所培養(yǎng)基，進口培養(yǎng)基等）

5 定制各種法定藥典外藥物雜質(zhì)（附COA及H-NMR，MS，HPLC圖譜），

6 各*試劑：阿拉丁、麥克林、Sigma

貨期準，到貨快，價格優(yōu)。歡迎來電垂詢！

展開顯示更多內(nèi)容

法定藥典標準品（如中檢所、美國中草藥標準品ChromaDex、USP、EP、BP、JP等），藥物代謝雜質(zhì)類產(chǎn)品（如英國LGC,加拿大TRC,TLC等）

產(chǎn)品簡介在線詢價

英國NIBSC標準物質(zhì) 上?？戮S化學(xué)優(yōu)惠供應(yīng)中
NIBSC種類繁多，由于網(wǎng)頁排版只列舉其中一部分產(chǎn)品，更多產(chǎn)品信息詳詢。

英國NIBSC標準物質(zhì) 產(chǎn)品信息

上海柯維化學(xué)供應(yīng)英國NIBSC標準品，美國 ATCC菌株，中檢所CMCC菌種，歡迎訂購。
多種規(guī)格型號可供選擇，定量質(zhì)控菌株，定性質(zhì)控菌株，單一菌株，菌株套裝等，使用方便，滿足您的實驗需求。

04/172   Influenza Virus infectious IVR-139
Influenza Reagent
04/176   Plasmodium falciparum DNA for NAT Assays(1st International Standard)
WHO International Standard
04/198   Anti-Meningococcal Serotype P3.1 mAb
Non WHO Reference Material
04/200   Parathyroid hormone 1-34 ,Recombinant, Human(International Standard)
WHO International Standard
04/202   Influenza Antigen B/ Jiangsu/10/2003
Influenza Reagent
04/214   Influenza Antiserum A/Viet Nam/1194/04 (H5N1)
Influenza Reagent
04/224   Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004
WHO International Standard
04/228   Influenza anti B/ Neuraminidase Serum
Influenza Reagent
04/242   Influenza anti B/Jiangsu/10/2003 HA Serum
Influenza Reagent
04/246   Anti-Meningococcal Serogroup W-135 mAb
Non WHO Reference Material
04/248   Anti-Meningococcal Serosubtype P1.19 mAb
Non WHO Reference Material
04/252   Protein C Concentrate, Human(1st International Standard)
WHO International Standard
04/260   Influenza anti A/New Caledonia/20/99 HA Serum
Influenza Reagent
04/262   Influenza anti A/New York/55/2004 HA Serum
Influenza Reagent
04/264   Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157)
Influenza Reagent
05/102   Influenza Virus infectious NYMC BX-7
Influenza Reagent
05/106   Anti-HPA-1a minimum potency reagent(2nd International Reference reagent)
International Reference Reagent
05/110   Influenza Virus infectious A/California/7/2004
Influenza Reagent
05/112   Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).
WHO International Standard
05/122   Syphilitic plasma IgG (human)(1st International Standard)
WHO International Standard
05/130   Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)
WHO International Standard
05/132   Syphilitic plasma IgG and IgM (human)(1st International Standard)
WHO International Standard
05/134   Anti-human papillomavirus type 16 serum (1st International Standard)
WHO International Standard
05/138   Influenza Virus infectious B/Shanghai/361/2002
Influenza Reagent
05/162   Alpha-1-Antitrypsin, plasma derived(1st International standard)
WHO International Standard
05/190   Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody
Non WHO Reference Material
05/192   Anti Meningococcal Serotype P2.2b Monoclonal Antibody
Non WHO Reference Material
05/234   Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142)
Influenza Reagent
05/236   Influenza anti A/Wisconsin/67/2005 Serum
Influenza Reagent
05/242   IVIG, Anti-D and Negative Control Panel
Non WHO Reference Material
05/252   Influenza anti B Neuraminidase Serum
Influenza Reagent
06/108   Influenza Virus infectious IVR-116
Influenza Reagent
06/114   Influenza Virus Infectious A/PR/8/34
Influenza Reagent
06/124   Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 2 (1st International Standard)
WHO International Standard
06/128   Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 3 (1st International Standard)
WHO International Standard
06/140   Pertussis Antiserum(human)1st IS-WHO international Standard.
WHO International Standard
06/142   Pertussis Antiserum (Human) 1st WHO Reference Reagent
International Reference Reagent
06/164   Influenza Virus infectious 1 VR-142
Influenza Reagent
06/166   Antithrombin Concentrate, Human (3rd International Standard)
WHO International Standard
06/170   Influenza Antigen A/New Caledonia/20/99
Influenza Reagent
06/192   Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466)
Influenza Reagent
06/202   Human Papillomavirus (HPV) Type 16 DNA (1st International Standard)
WHO International Standard
06/206   Human Papillomavirus (HPV) Type 18 DNA (1st International Standard)
WHO International Standard
06/242   Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR)
Influenza Reagent
07/102   Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145)
Influenza Reagent
07/104   Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum
Influenza Reagent
07/112   Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23
Influenza Reagent
07/132   Influenza Virus infectious B/Malaysia/2506/2004
Influenza Reagent
07/144   Influenza Virus infectious IVR-145,
Influenza Reagent
07/146   Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep)
Influenza Reagent
07/148   Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum
Influenza Reagent
07/150   Human Plasma Anti-Influenza H5N1 (1st International Standard)
WHO International Standard
07/164   Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)
WHO International Standard
07/184   Influenza anti B/Malaysia/2506/2004-HA Serum
Influenza Reagent
07/202   Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent)
International Reference Reagent
07/204   Influenza Virus Infectious NIBRG-60 VE2 25820
Influenza Reagent
07/214   Positive Control for use in flow cytometry cross matching (FCXM)
CE Marked Material
07/216   Diphtheria Toxoid (Adsorbed) (4th International Standard)
WHO International Standard
07/222   RhD/SRY Plasma DNA sensitivity standard (1st International Reference Reagent)
International Reference Reagent
07/226   Influenza Virus Infectious A/New Caledonia/20/99
Influenza Reagent
07/228   Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard”
WHO International Standard
07/246   Influenza Virus Infectious IVR-147
Influenza Reagent
07/268   Influenza Virus Infectious B/Brisbane/3/2007
Influenza Reagent
07/270   BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent)
International Reference Reagent
07/272   BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent)
International Reference Reagent
07/274   BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent)
International Reference Reagent
07/278   Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475)
Influenza Reagent
07/286-014   0.05 IU HBsAg Monitor Sample
CE Marked Material
07/288-016   Hepatitis B Surface Antigen British Working Standard 0.2 IU/ml
CE Marked Material
07/290   Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6
Influenza Reagent
07/294-006   Norovirus GII for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
07/296-006   Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
07/298-006   Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
07/300-005   Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
07/304   Anti-D for assuring operator and test performance
Working Standard
07/306   Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (International Reference Reagent)
International Reference Reagent
07/316   Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.)
WHO International Standard
07/318   Meningococcal Group C Polysaccharide
Non WHO Reference Material
07/326   Blood Coagulation Factors II, IX,and X Concentrate, 6th British Working Standard.
Working Standard
07/328   Unfractionated Heparin (6th I.S.)
WHO International Standard
07/336   Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60
Influenza Reagent
07/338   Influenza antiserum A/Anhui/1/05 (H5)
Influenza Reagent
07/348   Influenza Virus infectious NYMC X-171B
Influenza Reagent
07/350   Blood Coagulation Factor VIII Concentrate (8th I.S.)
WHO International Standard
07/358   Influenza Virus infectious NIB-50
Influenza Reagent
07/362   Influenza Virus infectious IVR-149
Influenza Reagent
07/364   Chorionic Gonadotrophin, (5th International Standard)
WHO International Standard
07/B498-18   QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1
Quality Control Reagent
08/100   Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1)
Influenza Reagent
08/108   Influenza Virus Infectious NIBRG-91
Influenza Reagent
08/118-005   Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
08/120-005   Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
08/126   Influenza Anti N1 Neuraminidase Serum SH485
Influenza Reagent
08/138   Influenza Virus Infectious B/Florida/4/2006
Influenza Reagent
08/140   Influenza Antigen B/Florida/4/2006
Influenza Reagent
08/142   Influenza antiserum A/Anhui/1/05 (H5)
Influenza Reagent
08/148   Positive control for Luminex based anti-HLA Class II serology
CE Marked Material
08/150   HIV-2 RNA(1st International Standard)
WHO International Standard
08/154   Influenza Virus Infectious NIBRG-12
Influenza Reagent
08/156   Influenza Virus Infectious NIBRG-23 30060 VE3
Influenza Reagent
08/158   Fragile X Syndrome gDNA (1st International Genetic Reference Panel)
WHO International Standard
08/160   Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel)
WHO International Standard
08/176-005   Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
08/178-005   Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
08/180-005   Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
08/184   Influenza Antigen B/Malaysia/2506/2004
Influenza Reagent
08/202   Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1)
Influenza Reagent
08/204   Thyroid Stimulating Antibody (2nd I.S.)
WHO International Standard
08/208   Influenza Antigen Hong Kong/1073/99 (H9N2)
Influenza Reagent
08/210   Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86)
Influenza Reagent
08/214   Meningococcal Serogroup C polysaccharide (1st International Standard)
WHO International Standard
08/216   Influenza Antigen A/Cambodia/RO405050/2007 (H5N1)
Influenza Reagent
08/218   Tetanus Toxoid Adsorbed (4th International Standard)
WHO International Standard
08/228   Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91
Influenza Reagent
08/230   Streptodornase (2nd International Standard)
WHO International Standard
08/246   Influenza anti A/Brisbane/10/2007- like HA serum
Influenza Reagent
08/256   C1- Inhibitor, Concentrate (1st International Standard)
WHO International Standard
08/258   Antithrombin, Plasma (3rd International Standard)
WHO International Standard
08/262   C1 Inhibitor (Plasma)(1st International Standard)
WHO International Standard
08/266   Sex Hormone Binding Globulin.(2nd International Standard)
WHO International Standard
08/268   Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107
Influenza Reagent
08/278   Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C))
Influenza Reagent
08/282   Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard)
WHO International Standard
08/298   Influenza Virus Infectious B/Brisbane/33/2008 30720 E5
Influenza Reagent
08/300   Influenza Virus Infectious IVR-148
Influenza Reagent